Chemotherapy for Leukemia: Novel Drugs and Treatment

Author:   Takanori Ueda
Publisher:   Springer Verlag, Singapore
Edition:   1st ed. 2017
ISBN:  

9789811033308


Pages:   361
Publication Date:   26 April 2017
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $422.37 Quantity:  
Add to Cart

Share |

Chemotherapy for Leukemia: Novel Drugs and Treatment


Add your own review!

Overview

Full Product Details

Author:   Takanori Ueda
Publisher:   Springer Verlag, Singapore
Imprint:   Springer Verlag, Singapore
Edition:   1st ed. 2017
Dimensions:   Width: 15.50cm , Height: 2.60cm , Length: 23.50cm
Weight:   6.785kg
ISBN:  

9789811033308


ISBN 10:   9811033307
Pages:   361
Publication Date:   26 April 2017
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1 An Overview.- Part I Bcr-Abl Tyrosine Kinase Inhibitors (TKIs).- 2 Imatinib: Basic Results.- 3 Imatinib: Clinical Pharmacology and Therapeutic Results.- 4 Dasatinib, Nilotinib, Bosutinib, Ponatinib, and Other TKIs.- Part II New Antibodies for Leukemia.- 5 Rituximab and Alemtuzumab for Chronic Lymphocytic Leukemia: Basic Results.- 6 Rituximab and Alemtuzumab for Chronic Lymphocytic Leukemia: Clinical Pharmacology and Therapeutic Results.- 7 Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia: Clinical Pharmacology and Therapeutic Results.- 8 Blinatumomab for Acute Lymphoblastic Leukemia: Clinical Pharmacology and Therapeutic Results.- 9 Mogamulizumab in Adult T-cell Leukemia/Lymphoma.- Part III Signaling inhibitors.- 10. FLT3 inhibitors.- Part IV Differentiating Agents.- 11 Retinoic Acid, All-Trans Retinoic Acid (ATRA) and Tamibarotene.- 12 The Molecular Basis of Arsenic Trioxide Treatment for Acute Promyelocytic Leukemia (APL).- 13 Arsenic Trioxide: Clinical Pharmacology and Therapeutic Results.- Part V New Chemotherapeutic Agents Including Antimetabolite.- 14 Nelarabine.- 15 Forodesine.- 16 Clofarabine: Structure, Mechanism of Action, and Clinical Pharmacology.- 17 Clinical Use of Clofarabine for Adults and Children with Leukemia.- 18 Re-Emerging Antimetabolites with Novel Mechanism of Action with Respect to Epigenetic Regulation: Basic Aspects.- 19 Epigenetic Regulator, Re-Emerging Antimetabolites with Novel Mechanism of Action (Azacitidine and Decitabine): Clinical Pharmacology and Therapeutic Results.- Part VI Therapy Targeting Leukemic Stem Cells.- 20 Therapies Targeting Leukemic Stem Cells.

Reviews

Author Information

Takanori Ueda Vice-President, University of Fukui Faculty of Medical Sciences, 3-9-1 Bunkyo, Fukui 910-8507, Japan

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List